Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Primary Antiphospholipid Syndrome
NCT06504420Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sirolimus in antiphospholipid syndrome (APS), sponsored by Peking University People's Hospital. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
sirolimus
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on NCT06504420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06504420.